4.6 Article

Spectroscopic and kinetic studies of Nor1, a cytochrome P450 nitric oxide reductase from the fungal pathogen Histoplasma capsulatum

Journal

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Volume 480, Issue 2, Pages 132-137

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.abb.2008.09.001

Keywords

Histoplasma capsulatum; Nitric oxide; Nitric oxide detoxification; Cytochrome P450; Cytochrome P450 nitric oxide reductase; Flavohemoglobin

Funding

  1. NIGMS NIH HHS [GM31105, R01 GM035827-20, R37 GM031105-27, GM35827, R01 GM035827, R01 GM031105, R37 GM031105] Funding Source: Medline

Ask authors/readers for more resources

The fungal respiratory pathogen Histoplasma capsulatum evades the innate immune response and colonizes macrophages during infection. Although macrophage production of the antimicrobial effector nitric oxide (NO) restricts H. capsulatum growth, the pathogen is able to establish a persistent infection. H. capsulatum contains a P450 nitric oxide reductase homologue (NOR1) that may be important for detoxifying NO during infection. To characterize the activity of this putative P450 enzyme, a 404 amino acid fragment of Nor1 p was expressed in Escherichia coli and purified to homogeneity. Spectral characterization of Nor1 p indicated that it was similar to other fungal P450 nitric oxide reductases. Nor1 p catalyzed the reduction of NO to N2O using NADH as the direct reductant. The K-m for NO was determined to be 20 mu M and the k(cat) to be 5000 min(-1). Together, these results provide evidence for a protective role of a P450 nitric oxide reductase against macrophage-derived NO. (c) 2008 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available